Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study.

Worm, Margitta; Rak, Sabina; de Blay, Frédéric; Malling, Hans-Jorgen; Melac, Michel; Cadic, Véronique; Zeldin, Robert K

Worm, Margitta; Rak, Sabina; de Blay, Frédéric; Malling, Hans-Jorgen; Melac, Michel; Cadic, Véronique; Zeldin, Robert K.

Afiliação

Worm M; Allergy-Centre-Charité, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.
Rak S; Asthma and Allergy Research Group, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Göteborg, Sweden.
de Blay F; Chest Diseases Department, Strasbourg University Hospital, Federation of Translational Medicine, University of Strasbourg, Strasbourg, France.
Malling HJ; Allergy Clinic, Gentofte University Hospital, Copenhagen, Denmark.
Melac M; Stallergenes S.A., Antony, France.
Cadic V; Stallergenes S.A., Antony, France.
Zeldin RK; Stallergenes S.A., Antony, France.

Clin Transl Allergy ; 4(1): 7, 2014 Feb 11.

Article em En | MEDLINE | ID: mdl-24517417

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Clin Transl Allergy Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google